A #tweetorial about the outcomes of hepatic coma, how far we have come, and how wild things got along the way #livertwitter
2/
Up first: the lingo
Hepatic encephalopathy (HE) presents as a spectrum with subtle cognitive/motor deficits at one end (AKA "Covert HE") and coma at the other
HE/Coma can be caused by #cirrhosis (Type C, more common) and acute liver failure (Type A)
3/
What used to (1950s/60s) happen to patients with coma due to hepatic encephalopathy ("HE coma")?
1⃣Gabuzda said everyone died
2⃣Sherlock said it was 68% mortality, Stormont 63%
3⃣Prytz said it was 80% mortality at 6-months
4/
HE coma was hopeless
And then, 1952-54, the big bang moment
We discovered ammonia as a trigger
While ammonia was n̳e̳v̳e̳r̳ thought to be the whole story, it was directly linked to HE and was a modifiable target
5/
Ammonia comes from the gut.
You know what reduces ammonia?
Antibiotics!
Maybe by changing bacterial or gut metabolism, maybe by changing the bacteria themselves
In 1955, Silen showed that neomycin ⬇️⬇️ammonia levels.
6/
So do antibiotics help in hepatic coma?
Many tried
Sadly, Not. good. enough.
7/
We also learned that the liver efficiently clears ammonia from the blood but not so much in #cirrhosis
Check out the "Ammonium Tolerance Test"
8/
💡Can we treat HE by cleaning the blood with healthy liver?
Step One:
In 1958, Otto created "Eck fistulas" (connect the SMV-IVC) in dogs.
He then hooked another dog liver up to a circuit with the femoral artery and vein.
It cleared the ammonia.
9/
Step two:
In 1961, Eiseman showed you could run blood through a liver removed from a recently deceased person. "Ex vivo" perfusion
It cleared the ammonia
10/
Step 3: Use it to treat hepatic coma
In 1965, an upstart surgeon named Starzl sewed a liver to the groin of comatose kids
In 1966, Sen reported 'ex vivo' perfusion of human livers hooked up to people in coma from acute liver failure or #cirrhosis
It rarely worked
11/
💡Do we really need to take the donor liver out of the body??
In 1965, Burnell teamed up with Scribner to do “dialysis” by cross-circulating the blood of a woman in hepatic coma into a man dying of cancer.
She woke up! (though she later died from GI bleeding)
12/
Despite poor outcomes, people were excited
But it was just not feasible to:
1⃣find people willing to be human dialysis machines
2⃣find suitable donors for ex-vivo liver perfusion
Two alternatives were considered
13/
First, people like Charlie Trey tried exchange transfusions.
Basically, replacing the blood with donor blood products.
It was mainly tried for acute viral hepatitis or halothane hepatitis.
Seemed promising.
But controlled trials failed.
14/
Second, many thought it would be easier to use animal livers
In 1965, Eiseman hooked up a pig liver to 8 patients with #cirrhosis in coma.
All patients died within 8 days.
But many woke up, including one man who requested a cigarette while still in the OR
15/
The concept of cross-circulation - liver dialysis using a living being - again took hold
In 1968, Christian Barnard published twin papers in @TheLancet describing how to do it with a baboon and the outcome in one young woman with #cirrhosis
She left the hospital
16/
Which brings me to Hume's 1969 description:
He brought an awake baboon to the bedside, immobilized him in a cast, flushed his blood out and replaced it with human blood, and then hooked him up to a patient in hepatic coma who would awake to find a baboon in the room.
17/
By the mid 1970's, animal-man cross-circulation was on the out
1⃣It was HARD
2⃣often ineffective
3⃣...complicated
4⃣👇And Starzl started getting good at liver transplantation
⭐️HE is a biomarker of badness
⭐️People with HE died of sepsis, bleeding, not HE!
⭐️We learned to treat the badness
Bam! our patients started surviving
Game changers
1⃣Endoscopy/banding
2⃣Good antibiotics
3⃣ICU care
4⃣Lactulose!
19/
Proof of progress: Remember how basically everyone in HE coma due to #cirrhosis used to die in the hospital?
1⃣By the 1970's, 49% died
2⃣By the 2000's, 30% died by 1-year
20/
Liver support (eg MARS) have been trialed, rarely improving HE in #cirrhosis
They havent ⬆️survival
But HE in acute liver failure is different
Patients still die waiting for transplant, keeping the liver support dream alive
See: pig perfusion redux, auxiliary tx
/Summary
☑️People with HE coma die because of the triggers: bleeding, infection.
☑️⬆️survival for coma due to HE is mostly a triumph for supportive care
☑️Patients in coma inspired us to try wild things, and ultimately led us to learn how to transplant
end/
This concludes a #tweetorial on the history of outcomes and management of hepatic encephalopathy coma. Thank you for reading. I hope you enjoyed.
Thank you to @BloomPringle for reviewing and @HPB_Txp_Surg for the story (with @PeterAttiaMD) that inspired this
• • •
Missing some Tweet in this thread? You can try to
force a refresh
It’s an enzyme that transfers amino acids to proteins. It's found anywhere things need transferring (liver cells, bile ducts, kidneys, heart....)
No big deal, right?
Wrong!
3/
It did not take long to figure out that while lots of conditions raised the GGT, liver disease and biliary obstruction were the best at making high GGT
First, I have mentors to thank. Dr Michelle Lai who gave me my start and launched me. @SenguptaNeil who taught me everything I know. And the reason I moved my family from Boston to a suburb of Detroit known away from good food, Dr Lok, the greatest mentor I will ever know
Second, I have advice. Find a place where you are surrounded by greatness and absorb it. It has been the great fortune of my life to work alongside and learn from people like JMellinger, @AkbarWaljee, and above all @NDP1001
We find that a clinicians' pre-test probability of HE is the same as the post-test probability. But! not only does Nh3 add nothing diagnostically, when high it leads to excess lactulose use even when tested in people without #cirrhosis
Now we need to design the QI intervention
I have always wanted to do this study. Huge thanks to @juanjgonMD 4 doing it. Even if u dont care about Nh3, we are very proud of our design, which allowed us to assess the value of a test using the clinician's real-time reasons for testing and prior probability